Literature DB >> 11746867

Antiviral activities of extracts isolated from Terminalis chebula Retz., Sanguisorba officinalis L., Rubus coreanus Miq. and Rheum palmatum L. against hepatitis B virus.

T G Kim1, S Y Kang, K K Jung, J H Kang, E Lee, H M Han, S H Kim.   

Abstract

The antiviral effects of aqueous extracts of Terminalis chebula Retz., Sanguisorba officinalis L., Rubus coreanus Miq. and Rheum palmatum L. were examined by a cell culture system using a hepatitis B virus (HBV) producing cell line, HepG2 2.2.15. The extracts were assayed for the inhibition of HBV multiplication by measurement of HBV DNA and surface antigen (HBsAg) levels in the extracellular medium of HepG2 2.2.15 cells after an 8-day treatment. All extracts decreased the levels of extracellular HBV virion DNA at concentrations ranging from 64 to 128 microg/mL and inhibited the secretion of HBsAg dose dependently. Of the four tested plants, Terminalis chebula exhibited the most prominent anti-HBV activities. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11746867     DOI： 10.1002/ptr.832

Source DB:  PubMed          Journal:  Phytother Res        ISSN： 0951-418X            Impact factor:   5.878


  15 in total

Review 1.  Ethnobotanical Uses, Phytochemistry and Pharmacology of Different Rheum Species (Polygonaceae): A Review.

Authors:  Leila Mohtashami; Mohammad Sadegh Amiri; Zahra Ayati; Mahin Ramezani; Tannaz Jamialahmadi; Seyed Ahmad Emami; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Studies on the antiviral activity of chebulinic acid against dengue and chikungunya viruses and in silico investigation of its mechanism of inhibition.

Authors:  Naiju Thomas; Poonam Patil; Anjana Sharma; Sandeep Kumar; Vikas Kumar Singh; Kalichamy Alagarasu; Deepti Parashar; Suman Tapryal
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

Review 3.  Anti-hepatitis B activities of Myanmar medicinal plants: a narrative review of current evidence.

Authors:  Ye Htut Linn; Win Win Ei; Lwin Mon Mon Myint; Khin Maung Lwin
Journal:  Virusdisease       Date:  2021-07-14

4.  Frangulosid as a novel hepatitis B virus DNA polymerase inhibitor: a virtual screening study.

Authors:  Mokhtar Nosrati; Zahra Shakeran; Zainab Shakeran
Journal:  In Silico Pharmacol       Date:  2018-05-17

5.  Study on the antiviral activity of San Huang Yi Gan Capsule against hepatitis B virus with seropharmacological method.

Authors:  Haibo Xu; Qinghe Wu; Cheng Peng; Lijuan Zhou
Journal:  BMC Complement Altern Med       Date:  2013-09-27       Impact factor: 3.659

Review 6.  Immunomodulatory effects of triphala and its individual constituents: a review.

Authors:  Pranoti Belapurkar; Pragya Goyal; Preeti Tiwari-Barua
Journal:  Indian J Pharm Sci       Date:  2014 Nov-Dec       Impact factor: 0.975

7.  Inhibition of endosomal fusion activity of influenza virus by Rheum tanguticum (da-huang).

Authors:  Ta-Jen Lin; Chwan-Fwu Lin; Cheng-Hsun Chiu; Ming-Chung Lee; Jim-Tong Horng
Journal:  Sci Rep       Date:  2016-06-15       Impact factor: 4.379

8.  Preclinical Evaluation of In Vitro and In Vivo Antiviral Activities of KCT-01, a New Herbal Formula against Hepatitis B Virus.

Authors:  Hong Kim; Eungyeong Jang; So-Young Kim; Ji-Yoon Choi; Na-Rae Lee; Dae-Sung Kim; Kyung-Tae Lee; Kyung-Soo Inn; Bum-Joon Kim; Jang-Hoon Lee
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-04       Impact factor: 2.629

9.  Screening of neuraminidase inhibitory activities of some medicinal plants traditionally used in Lingnan Chinese medicines.

Authors:  Jiawei Liu; Mian Zu; Kaotan Chen; Li Gao; Huan Min; Weiling Zhuo; Weiwen Chen; Ailin Liu
Journal:  BMC Complement Altern Med       Date:  2018-03-20       Impact factor: 3.659

Review 10.  Triphala: current applications and new perspectives on the treatment of functional gastrointestinal disorders.

Authors:  Aleksandra Tarasiuk; Paula Mosińska; Jakub Fichna
Journal:  Chin Med       Date:  2018-07-18       Impact factor: 5.455
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.